CATHEPSIN-HEMMER

European patent · EP4046987 · In force

Register entry

Publication number
EP4046987
Application number
EP22150956
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 5, 2018
Published
Aug 24, 2022
Granted
Aug 27, 2025
Protection ends at the latest
Dec 4, 2038
Next annual fee due
Dec 31, 2026
IPC classes
C07C 317/14 (2006.01)
A61K 31/165 (2006.01)
A61P 19/10 (2006.01)
Priority
NL 2020021 05.12.2017
NL 2021544 03.09.2018
Divided from
EP18839759
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 8, 2026

    Change

    Published in Swissreg on 08.07.2026

  2. Jan 6, 2026

    Next annual fee due on

    Next annual fee due on
    31.12.2025 → 31.12.2026

    Published in Swissreg on 06.01.2026

  3. Oct 16, 2025

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 16.10.2025

  4. Aug 27, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 27.08.2025

Parties

Holder

Academisch Ziekenhuis Leiden h.o.d.n. LUMC

Academisch Ziekenhuis Leiden (h.o.d.n. LUMC)

Albinusdreef 2, 2333 ZA Leiden, NL

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

OVAA, Huib

2333 ZA Leiden, NL

MONS, Maria, Wilhelmina, Elisabet

2333 ZA Leiden, NL

VAN BOECKEL, Stan

2333 ZA Leiden, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.